Eskisehir Osmangazi University Medical Faculty
Eskisehir, Turkey
University in Turkey
Büyükdere Meşelik Yerleşkesi, 26040 Odunpazarı/Eskişehir
About Eskisehir Osmangazi University Medical Faculty
Eskisehir Osmangazi University, abbreviated as ESOGU, is located in Eskişehir, in the Eskişehir Province of Turkey.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Eskisehir Osmangazi University Medical Faculty
During the past decade, Eskisehir Osmangazi University Medical Faculty conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 6 clinical trials were completed, i.e. on
average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
2010-11-01
2016-03-01
Completed
261
A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures.
2014-09-16
2018-03-13
Completed
175
Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
2014-11-27
2018-08-14
Completed
5,390
A Non-interventional,Observational Post Authorization Study of Patients With Multiple Myeloma Treated With Lenalidomide TR
2013-12-25
2022-12-31
Unknown status
500
Nutritional Status of Cerebral Palsy Patients in Turkey
2015-11-01
2016-04-01
Completed
1,123
Efficiency and Safety of Pleural Biopsy Methods in the Diagnosis of Pleural Diseases
2011-02-08
2017-04-30
Completed
164
A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis
2017-07-12
2020-11-10
Completed
741
MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035)
2018-04-03
2020-03-16
Completed
94
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Eskisehir Osmangazi University Medical Faculty" #1 sponsor was "Bayer" with 4 trials, followed by "Abbott Nutrition" with 2 trials
sponsored, "Camurus AB" with 2 trials sponsored, "Diskapi Teaching and Research Hospital" with 2 trials sponsored and "Eskisehir Osmangazi University"
with 2 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Eskisehir Osmangazi University Medical Faculty"
#1 collaborator was "Klinar CRO" with 2 trials as a collaborator, "Regeneron Pharmaceuticals" with 2 trials as a collaborator, "Turkish Neurological Society" with 2 trials as a collaborator, "Abbott Nutrition" with 1 trials as a collaborator and "ElectroCore INC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at Eskisehir Osmangazi University Medical Faculty
According to Clinical.Site data, the most researched conditions in "Eskisehir Osmangazi University Medical Faculty" are
"Acromegaly" (2 trials), "Blood Transfusion" (2 trials), "Heart Failure" (2 trials), "Retinopathy of Prematurity (ROP)" (2 trials) and "Stroke" (2 trials). Many other conditions were trialed in "Eskisehir Osmangazi University Medical Faculty" in a lesser frequency.
Clinical Trials Intervention Types at Eskisehir Osmangazi University Medical Faculty
Most popular intervention types in "Eskisehir Osmangazi University Medical Faculty" are "Drug" (13 trials), "Other" (5 trials), "Procedure" (3 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Blood transfusion" (2 trials), "CAM2029 (octreotide subcutaneous depot)" (2 trials), "Ceftolozane/Tazobactam" (2 trials) and "Eylea (Aflibercept, BAY86-5321)" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Eskisehir Osmangazi University Medical Faculty
The vast majority of trials in "Eskisehir Osmangazi University Medical Faculty" are
23 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Eskisehir Osmangazi University Medical Faculty
Currently, there are NaN active trials in "Eskisehir Osmangazi University Medical Faculty".
undefined are not yet recruiting,
3 are recruiting,
4 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 16 completed trials in Eskisehir Osmangazi University Medical Faculty,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Eskisehir Osmangazi University Medical Faculty, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 5 trials that are defined as “Not Applicable".